Thalidomide complete remission in Schnitzler syndrome
Worm M, Kolde G
Br J Dermatol 148(3):601-2 · 2003
Abstract
[Abstract not available]
Key Findings
- ●Thalidomide complete remission in 2 patients
- ●Limited by polyneuropathy risk
Subject Classification
HumansImmunosuppressive AgentsInterleukin-6Schnitzler SyndromeThalidomideTreatment OutcomeTumor Necrosis Factor-alpha
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-12653766DOI: 10.1046/j.1365-2133.2003.05129.xPMID: 12653766